At a glance
ClinicalIndex Comparison RecordN/ACompleted· 271 enrolled
Drug / intervention
BioMimics 3D Vascular Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
MIMICS-2: Evaluation of Safety and Effectiveness of the BioMimics 3D Stent System in the Femoropopliteal Arteries of Patients With Symptomatic Peripheral Arterial Disease
In Brief
A clinical study evaluating BioMimics 3D Vascular Stent System for Peripheral Arterial Disease. Completed, enrolled 271 participants across 43 sites in 3 countries.
Detailed Summary
To demonstrate that the BioMimics 3D Stent System meets the performance goals defined by VIVA Physicians, Inc. for the safety and effectiveness of Nitinol stents used in the treatment of symptomatic disease of the femoropopliteal artery. It is a prospective, single-arm, multicenter clinical trial.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesGermany, Japan, United States
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 2015
Enrollment StartJun 2015
Primary CompletionNov 2017
Study CompletionDec 2019
TodayJul 2026
First PostedMar 27, 2015
Enrollment StartJun 29, 2015
Primary CompletionNov 3, 2017
Study CompletionDec 3, 2019
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 11.3 years ago
Interventions
BioMimics 3D Vascular Stent Systemdevice
Femoropopliteal stenting